Literature DB >> 16912057

Increased IRS-2 content and activation of IGF-I pathway contribute to enhance beta-cell mass in fetuses from undernourished pregnant rats.

Elisa Fernández1, M Angeles Martín, Susana Fajardo, Fernando Escrivá, Carmen Alvarez.   

Abstract

We have previously shown that fetuses from undernourished (U) pregnant rats exhibited an increased beta-cell mass probably related to an enhanced IGF-I replicative response. Because IGF-I signaling pathways have been implicated in regulating beta-cell growth, we investigated in this study the IGF-I transduction system in U fetuses. To this end, an in vitro model of primary fetal islets was developed to characterize glucose/IGF-I-mediated signaling that specially influences beta-cell proliferation. We found that U fetal islets showed a greater replicative response to glucose and IGF-I than controls. Furthermore, insulin receptor substrate (IRS)-2 protein and its association with p85 were also increased. In the complete absence of IGF-I or stimulatory glucose, U islets presented an increased basal phosphorylation of downstream signals of the phosphatidylinositol 3-kinase (PI3K) pathway such as PKB, glycogen synthase kinase (GSK)3alpha/beta, PKCzeta, and mammalian target of rapamycin (mTOR). Similarly, phosphorylation of these proteins (except GSK3alpha/beta) by glucose and IGF-I was augmented even though total protein content remained unchanged. Downstream of PKB, direct glucose activation of mTOR was increased as well. In contrast, ERK1/2 phosphorylation was unaffected by undernutrition, but ERK activation seemed to be required to induce a higher proliferative response in U islets. In conclusion, we have demonstrated that fetal U islets show increased IRS-2 content and an enhancement in both basal and glucose/IGF-I activations of the IRS-2/PI3K/PKB pathway. These molecular changes may be responsible for the greater glucose/IGF-I islet replication and contribute to the increased beta-cell mass found in these fetuses.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16912057     DOI: 10.1152/ajpendo.00283.2006

Source DB:  PubMed          Journal:  Am J Physiol Endocrinol Metab        ISSN: 0193-1849            Impact factor:   4.310


  8 in total

1.  Role of endogenous IL-6 in the neonatal expansion and functionality of Wistar rat pancreatic alpha cells.

Authors:  E Fernández-Millán; J de Toro-Martín; E Lizárraga-Mollinedo; F Escrivá; C Álvarez
Journal:  Diabetologia       Date:  2013-02-23       Impact factor: 10.122

Review 2.  Redox stress and signaling during vertebrate embryonic development: Regulation and responses.

Authors:  Alicia R Timme-Laragy; Mark E Hahn; Jason M Hansen; Archit Rastogi; Monika A Roy
Journal:  Semin Cell Dev Biol       Date:  2017-09-22       Impact factor: 7.727

3.  CRFR1 activation protects against cytokine-induced β-cell death.

Authors:  Lykke Blaabjerg; Gitte L Christensen; Masahito Matsumoto; Talitha van der Meulen; Mark O Huising; Nils Billestrup; Wylie W Vale
Journal:  J Mol Endocrinol       Date:  2014-10-16       Impact factor: 5.098

4.  Increased pancreatic islet mass is accompanied by activation of the insulin receptor substrate-2/serine-threonine kinase pathway and augmented cyclin D2 protein levels in insulin-resistant rats.

Authors:  Alex Rafacho; Daniele Lisboa Ribeiro; Antonio Carlos Boschero; Sebastião Roberto Taboga; José Roberto Bosqueiro
Journal:  Int J Exp Pathol       Date:  2008-04-21       Impact factor: 1.925

Review 5.  Early-life origins of type 2 diabetes: fetal programming of the beta-cell mass.

Authors:  Bernard Portha; Audrey Chavey; Jamileh Movassat
Journal:  Exp Diabetes Res       Date:  2011-10-24

6.  Pro-oxidant/antioxidant balance controls pancreatic β-cell differentiation through the ERK1/2 pathway.

Authors:  E Hoarau; V Chandra; P Rustin; R Scharfmann; B Duvillie
Journal:  Cell Death Dis       Date:  2014-10-23       Impact factor: 8.469

7.  The Constitutive Lack of α7 Nicotinic Receptor Leads to Metabolic Disorders in Mouse.

Authors:  Blandine Gausserès; Junjun Liu; Ewout Foppen; Cécile Tourrel-Cuzin; Ana Rodriguez Sanchez-Archidona; Etienne Delangre; Céline Cruciani-Guglielmacci; Stéphanie Pons; Uwe Maskos; Bernard Thorens; Christophe Magnan; Jamileh Movassat; Kamel Maouche
Journal:  Biomolecules       Date:  2020-07-16

8.  Mutant Huntingtin Impairs Pancreatic β-cells by Recruiting IRS-2 and Disturbing the PI3K/AKT/FoxO1 Signaling Pathway in Huntington's Disease.

Authors:  Li Li; Yun Sun; Yinong Zhang; Weixi Wang; Cuifang Ye
Journal:  J Mol Neurosci       Date:  2021-07-31       Impact factor: 3.444

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.